Consistent with clinical gastric cancer samples, Mist1 was downregulated in dysplasia and neoplasia specimens, while PCNA, a nuclear marker of proliferation, was significantly upregulated in comparison with its expression in the control group (Fig. 1F). Here, PCNA is linked to dysplasia.